These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 31180743)

  • 1. Aripiprazole for treating irritability associated with autism spectrum disorders.
    Bartram LA; Lozano J; Coury DL
    Expert Opin Pharmacother; 2019 Aug; 20(12):1421-1427. PubMed ID: 31180743
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole for autism spectrum disorders (ASD).
    Hirsch LE; Pringsheim T
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009043. PubMed ID: 27344135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.
    Rizzo R; Pavone P
    Expert Rev Neurother; 2016 Aug; 16(8):867-74. PubMed ID: 27388494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA
    Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
    Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
    Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotics for behavioral problems in children.
    Shafiq S; Pringsheim T
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole for autism spectrum disorders (ASD).
    Ching H; Pringsheim T
    Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne Muscular Dystrophy Successfully Treated with Aripiprazole in a Patient with Autism Spectrum Disorder Symptoms Including Irritability.
    Noda S; Murakami A; Kimura S; Minamiyama M; Katsuno M; Kuru S
    Intern Med; 2021 Dec; 60(24):3983-3986. PubMed ID: 34148958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Hellings JA; Arnold LE; Han JC
    Expert Opin Pharmacother; 2017 Apr; 18(6):581-588. PubMed ID: 28335658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole for the treatment of irritability associated with autism.
    Farmer CA; Aman MG
    Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Yokukansan, a Japanese Kampo Medicine for Symptoms Associated Autism Spectrum Disorder.
    Wake R; Miyaoka T; Furuya M; Hashioka S; Horiguchi J
    CNS Neurol Disord Drug Targets; 2016; 15(5):551-63. PubMed ID: 27071791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Autism Spectrum Disorder in Children and Adolescents.
    DeFilippis M; Wagner KD
    Psychopharmacol Bull; 2016 Aug; 46(2):18-41. PubMed ID: 27738378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M; Erickson CA
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
    Anagnostou E
    Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.
    Lamy M; Pedapati EV; Dominick KL; Wink LK; Erickson CA
    Paediatr Drugs; 2020 Oct; 22(5):473-483. PubMed ID: 32686015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder.
    Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
    Ichikawa H; Hiratani M; Yasuhara A; Tsujii N; Oshimo T; Ono H; Tadori Y
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):84-94. PubMed ID: 28941259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.